Cohere Health vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $50M equity ($106M total). Processes 5.5M prior authorizations/year for 15M health plan members and 420,000 providers. CMS 2026 deadline a direct growth catalyst.
About
Cohere Health (not affiliated with the AI company Cohere) is a prior authorization intelligence platform operating on the payer side of healthcare — a differentiated position from provider-facing prior auth tools. The company has raised $106 million in total equity financing and processes 5.5 million prior authorizations annually covering 15 million health plan members and 420,000 provider relationships for its health plan customers.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.